Identification of a Novel Potent CYP4Z1 Inhibitor Attenuating the Stemness of Breast Cancer Cells Through Lead Optimization

In order to develop potent and selective CYP4Z1 inhibitors, a series of novel N-hydroxyphenylformamidines were rationally designed and synthesized from a pan-CYP inhibitor HET0016.
[Journal of Medicinal Chemistry]
AbstractGraphical Abstract

Stay up-to-date with your field!

Subscribe for free weekly science newsletters.

Related News